Cargando…
Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia
Astrogliosis and activation of microglia are hallmarks of prion diseases in humans and animals. Both were viewed to be rather independent events in disease pathophysiology, with proinflammatory microglia considered to be the potential neurotoxic species at late disease stages. Recent investigations...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530067/ https://www.ncbi.nlm.nih.gov/pubmed/31118110 http://dx.doi.org/10.1186/s40478-019-0735-1 |
_version_ | 1783420542151294976 |
---|---|
author | Hartmann, Kristin Sepulveda-Falla, Diego Rose, Indigo V. L. Madore, Charlotte Muth, Christiane Matschke, Jakob Butovsky, Oleg Liddelow, Shane Glatzel, Markus Krasemann, Susanne |
author_facet | Hartmann, Kristin Sepulveda-Falla, Diego Rose, Indigo V. L. Madore, Charlotte Muth, Christiane Matschke, Jakob Butovsky, Oleg Liddelow, Shane Glatzel, Markus Krasemann, Susanne |
author_sort | Hartmann, Kristin |
collection | PubMed |
description | Astrogliosis and activation of microglia are hallmarks of prion diseases in humans and animals. Both were viewed to be rather independent events in disease pathophysiology, with proinflammatory microglia considered to be the potential neurotoxic species at late disease stages. Recent investigations have provided substantial evidence that a proinflammatory microglial cytokine cocktail containing TNF-α, IL-1α and C1qa reprograms a subset of astrocytes to change their expression profile and phenotype, thus becoming neurotoxic (designated as A1-astrocytes). Knockout or antibody blockage of the three cytokines abolish formation of A1-astrocytes, therefore, this pathway is of high therapeutic interest in neurodegenerative diseases. Since astrocyte polarization profiles have never been investigated in prion diseases, we performed several analyses and could show that C3(+)-PrP(Sc)-reactive-astrocytes, which may represent a subtype of A1-astrocytes, are highly abundant in prion disease mouse models and human prion diseases. To investigate their impact on prion disease pathophysiology and to evaluate their potential therapeutic targeting, we infected TNF-α, IL-1α, and C1qa Triple-KO mice (TKO-mice), which do not transit astrocytes into A1, with prions. Although formation of C3(+)-astrocytes was significantly reduced in prion infected Triple-KO-mice, this did not affect the amount of PrP(Sc) deposition or titers of infectious prions. Detailed characterization of the astrocyte activation signature in thalamus tissue showed that astrocytes in prion diseases are highly activated, showing a mixed phenotype that is distinct from other neurodegenerative diseases and were therefore termed C3(+)-PrP(Sc)-reactive-astrocytes. Unexpectedly, Triple-KO led to a significant acceleration of prion disease course. While pan-astrocyte and -microglia marker upregulation was unchanged compared to WT-brains, microglial homeostatic markers were lost early in disease in TKO-mice, pointing towards important functions of different glia cell types in prion diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0735-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6530067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65300672019-05-28 Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia Hartmann, Kristin Sepulveda-Falla, Diego Rose, Indigo V. L. Madore, Charlotte Muth, Christiane Matschke, Jakob Butovsky, Oleg Liddelow, Shane Glatzel, Markus Krasemann, Susanne Acta Neuropathol Commun Research Astrogliosis and activation of microglia are hallmarks of prion diseases in humans and animals. Both were viewed to be rather independent events in disease pathophysiology, with proinflammatory microglia considered to be the potential neurotoxic species at late disease stages. Recent investigations have provided substantial evidence that a proinflammatory microglial cytokine cocktail containing TNF-α, IL-1α and C1qa reprograms a subset of astrocytes to change their expression profile and phenotype, thus becoming neurotoxic (designated as A1-astrocytes). Knockout or antibody blockage of the three cytokines abolish formation of A1-astrocytes, therefore, this pathway is of high therapeutic interest in neurodegenerative diseases. Since astrocyte polarization profiles have never been investigated in prion diseases, we performed several analyses and could show that C3(+)-PrP(Sc)-reactive-astrocytes, which may represent a subtype of A1-astrocytes, are highly abundant in prion disease mouse models and human prion diseases. To investigate their impact on prion disease pathophysiology and to evaluate their potential therapeutic targeting, we infected TNF-α, IL-1α, and C1qa Triple-KO mice (TKO-mice), which do not transit astrocytes into A1, with prions. Although formation of C3(+)-astrocytes was significantly reduced in prion infected Triple-KO-mice, this did not affect the amount of PrP(Sc) deposition or titers of infectious prions. Detailed characterization of the astrocyte activation signature in thalamus tissue showed that astrocytes in prion diseases are highly activated, showing a mixed phenotype that is distinct from other neurodegenerative diseases and were therefore termed C3(+)-PrP(Sc)-reactive-astrocytes. Unexpectedly, Triple-KO led to a significant acceleration of prion disease course. While pan-astrocyte and -microglia marker upregulation was unchanged compared to WT-brains, microglial homeostatic markers were lost early in disease in TKO-mice, pointing towards important functions of different glia cell types in prion diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0735-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-22 /pmc/articles/PMC6530067/ /pubmed/31118110 http://dx.doi.org/10.1186/s40478-019-0735-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hartmann, Kristin Sepulveda-Falla, Diego Rose, Indigo V. L. Madore, Charlotte Muth, Christiane Matschke, Jakob Butovsky, Oleg Liddelow, Shane Glatzel, Markus Krasemann, Susanne Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title | Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title_full | Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title_fullStr | Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title_full_unstemmed | Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title_short | Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
title_sort | complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530067/ https://www.ncbi.nlm.nih.gov/pubmed/31118110 http://dx.doi.org/10.1186/s40478-019-0735-1 |
work_keys_str_mv | AT hartmannkristin complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT sepulvedafalladiego complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT roseindigovl complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT madorecharlotte complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT muthchristiane complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT matschkejakob complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT butovskyoleg complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT liddelowshane complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT glatzelmarkus complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia AT krasemannsusanne complement3astrocytesarehighlyabundantinpriondiseasesbuttheirabolishmentledtoanaccelerateddiseasecourseandearlydysregulationofmicroglia |